Baker Avenue Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-264
| Closed | -$32.3K | – | 877 |
|
|
2023
Q3 | $32.3K | Hold |
264
| – | – | ﹤0.01% | 579 |
|
|
2023
Q2 | $33.5K | Sell |
264
-2,120
| -89% | -$275K | ﹤0.01% | 577 |
|
|
2023
Q1 | $308K | Buy |
2,384
+1,070
| +81% | +$140K | 0.02% | 303 |
|
|
2022
Q4 | $173K | Sell |
1,314
-2,381
| -64% | -$308K | 0.01% | 337 |
|
|
2022
Q3 | $432K | Buy |
3,695
+1,737
| +89% | +$216K | 0.03% | 249 |
|
|
2022
Q2 | $230K | Sell |
1,958
-53,373
| -96% | -$6.34M | 0.02% | 288 |
|
|
2022
Q1 | $7.21M | Buy |
55,331
+2,898
| +6% | +$377K | 0.39% | 74 |
|
|
2021
Q4 | $8M | Buy |
52,433
+4,469
| +9% | +$692K | 0.41% | 69 |
|
|
2021
Q3 | $7.75M | Buy |
47,964
+1,122
| +2% | +$189K | 0.45% | 60 |
|
|
2021
Q2 | $7.67M | Buy |
46,842
+6,955
| +17% | +$1.07M | 0.45% | 59 |
|
|
2021
Q1 | $6M | Buy |
39,887
+324
| +0.8% | +$51.5K | 0.38% | 67 |
|
|
2020
Q4 | $5.99M | Sell |
39,563
-627
| -2% | -$89.6K | 0.41% | 62 |
|
|
2020
Q3 | $5.44M | Sell |
40,190
-1,966
| -5% | -$267K | 0.42% | 54 |
|
|
2020
Q2 | $5.76M | Sell |
42,156
-7,263
| -15% | -$926K | 0.47% | 47 |
|
|
2020
Q1 | $5.32M | Sell |
49,419
-59,879
| -55% | -$6.89M | 0.63% | 28 |
|
|
2019
Q4 | $13.2M | Buy |
109,298
+4,672
| +4% | +$521K | 0.95% | 23 |
|
|
2019
Q3 | $10.4M | Buy |
104,626
+589
| +0.6% | +$61.7K | 0.83% | 29 |
|
|
2019
Q2 | $11.3M | Sell |
104,037
-1,924
| -2% | -$205K | 0.92% | 27 |
|
|
2019
Q1 | $11.8M | Sell |
105,961
-8,806
| -8% | -$966K | 0.98% | 25 |
|
|
2018
Q4 | $11.1M | Buy |
114,767
+71,837
| +167% | +$7.62M | 1.09% | 25 |
|
|
2018
Q3 | $5.24M | Sell |
42,930
-58
| -0.1% | -$6.83K | 0.43% | 65 |
|
|
2018
Q2 | $4.72M | Sell |
42,988
-104
| -0.2% | -$11.1K | 0.41% | 63 |
|
|
2018
Q1 | $4.6M | Buy |
43,092
+938
| +2% | +$104K | 0.42% | 64 |
|
|
2017
Q4 | $4.5M | Buy |
42,154
+469
| +1% | +$50.1K | 0.43% | 61 |
|
|
2017
Q3 | $4.63M | Sell |
41,685
-492
| -1% | -$52.6K | 0.52% | 52 |
|
|
2017
Q2 | $4.36M | Sell |
42,177
-273
| -0.6% | -$26.9K | 0.58% | 50 |
|
|
2017
Q1 | $4.15M | Buy |
42,450
+6,753
| +19% | +$647K | 0.56% | 51 |
|
|
2016
Q4 | $3.16M | Sell |
35,697
-8,619
| -19% | -$784K | 0.44% | 62 |
|
|
2016
Q3 | $4.28M | Buy |
+44,316
| New | +$4.22M | 0.61% | 50 |
|
|
2014
Q3 | – | Sell |
-6,750
| Closed | -$578K | – | 290 |
|
|
2014
Q2 | $578K | Buy |
+6,750
| New | +$532K | 0.08% | 151 |
|
|
2014
Q1 | – | Sell |
-6,000
| Closed | -$454K | – | 226 |
|
|
2013
Q4 | $454K | Sell |
6,000
-1,500
| -20% | -$106K | 0.09% | 131 |
|
|
2013
Q3 | $524K | Sell |
7,500
-22,500
| -75% | -$1.47M | 0.11% | 124 |
|
|
2013
Q2 | $1.74M | Buy |
+30,000
| New | +$1.73M | 0.43% | 75 |
|
Other funds holding IBB
CB
